Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

PMID: 35338084
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Vidal, Noemi, Garcia-Carbonero, Rocio, Bazan-Peregrino, Miriam, Gil-Martin, Marta, Alvarez, Rafael, Macarulla, Teresa, Riesco-Martinez, Maria C, Verdaguer, Helena, Guillen-Ponce, Carmen, Farrera-Sal, Marti et al.
DOI: 10.1136/jitc-2021-003255

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

PMID: 35338084
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255.
Impact factor:
Publication type: Paper in international publication
Authors: Alemany, Ramon; Alvarez, Rafael; Bazan-Peregrino, Miriam; Blasco, Carmen; Blasi, Emma; Capella, Gabriel; Cascallo, Manel; Costa, Marcel; Del Pozo, Natalia; Farrera-Sal, Marti et al.
DOI: 10.1136/jitc-2021-003255

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.

PMID: 35815644
Journal: Future Oncology
Year: 2022
Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11.
Impact factor: 3.404
Publication type: Review in international publication
Authors: Studeny, Matus, Liu, Meiruo, Hamed, Zohra Oum', Morgensztern, Daniel, Kuboki, Yasutoshi, Gambardella, Valentina, Felip, Enriqueta, Wermke, Martin, Owonikoko, Taofeek K et al.
DOI: 10.2217/fon-2022-0196

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.

PMID: 35815644
Journal: Future Oncology
Year: 2022
Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11.
Impact factor:
Publication type: Review in international publication
Authors: Felip, Enriqueta; Gambardella, Valentina; Hamed, Zohra Oum'; Kuboki, Yasutoshi; Liu, Meiruo; Morgensztern, Daniel; Owonikoko, Taofeek K; Studeny, Matus; Wermke, Martin et al.
DOI: 10.2217/fon-2022-0196

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

PMID: 35298959
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Santoro, Armando, Su, Wu-Chou, Simonelli, Matteo, Ch Yang, James, Ardizzoni, Andrea, Barlesi, Fabrice, Hyoung Kang, Jin, DiDominick, Sarah, Abdelhady, Ahmed, Chen, Xueying et al.
DOI: 10.1016/j.lungcan.2022.02.010

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

PMID: 35298959
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Impact factor:
Publication type: Paper in international publication
Authors: Abdelhady, Ahmed; Ardizzoni, Andrea; Barlesi, Fabrice; Ch Yang, James; Chen, Xueying; DiDominick, Sarah; Felip, Enriqueta; Hyoung Kang, Jin; Navarro, Alejandro; Santoro, Armando et al.
DOI: 10.1016/j.lungcan.2022.02.010

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

PMID: 35305400
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16.
Impact factor: 6.54
Publication type: Paper in international publication
Authors: Tabernero, J, Andre, F, Blay, J-Y, Bustillos, A, Fear, S, Ganta, S, Jaeger, D, Maio, M, Mileshkin, L, Melero, I et al.
DOI: 10.1016/j.esmoop.2022.100419

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

PMID: 35305400
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16.
Impact factor:
Publication type: Paper in international publication
Authors: Andre, F; Blay, J-Y; Bustillos, A; Fear, S; Ganta, S; Jaeger, D; Maio, M; Melero, I; Mileshkin, L; Tabernero, J et al.
DOI: 10.1016/j.esmoop.2022.100419

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

PMID: 35257949
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Ozguroglu, Mustafa, Rodriguez Abreu, Delvys, Adeniji, Abidemi, Lorence, Robert M, Voccia, Isabelle, Chisamore, Michael J, Riess, Jonathan W, Molinier, Olivier, Madelaine, Jeannick, Kim, Sang-We et al.
DOI: 10.1016/j.lungcan.2022.01.023

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

PMID: 35257949
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3.
Impact factor:
Publication type: Paper in international publication
Authors: Adeniji, Abidemi; Barlesi, Fabrice; Bennouna, Jaafar; Chisamore, Michael J; Erman, Mustafa; Felip, Enriqueta; Isla, Dolores; Kim, Sang-We; Levy, Benjamin; Lorence, Robert M et al.
DOI: 10.1016/j.lungcan.2022.01.023

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer.

PMID: 35912190
Journal: Frontiers in Oncology
Year: 2022
Reference: Front Oncol. 2022 Jul 14;12:891886. doi: 10.3389/fonc.2022.891886. eCollection 2022.
Impact factor:
Publication type: Paper in international publication
Authors: Gomez-Iturriaga, Alfonso; Hervas-Moron, Asuncion; Lara, Pedro C; Lozano, Antonio; Maldonado, Xavier; Palacios-Eito, Amalia; Rodriguez-Melcon, Juan I; Sancho, Gemma; Villafranca, Elena et al.
DOI: 10.3389/fonc.2022.891886

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.

PMID: 35217575
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela et al.
DOI: 10.1136/jitc-2021-003776

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.

PMID: 35217575
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776.
Impact factor:
Publication type: Paper in international publication
Authors: Akerley, Wallace; Askoxylakis, Vasileios; Carion, Ana; Carvajal, Richard D; Chowdhury, Niladri Roy; De Braud, Filippo; Deschler-Baier, Barbara; Esaki, Taito; Gusenleitner, Daniel; Hong, David S et al.
DOI: 10.1136/jitc-2021-003776

Phenotypes of idiopathic pulmonary arterial hypertension.

PMID: 36179740
Journal: Lancet Respiratory Medicine
Year: 2022
Reference: Lancet Respir Med. 2022 Oct;10(10):e87. doi: 10.1016/S2213-2600(22)00290-9.
Impact factor:
Publication type: Letter or abstract
Authors: Cruz-Utrilla, Alejandro; Escribano-Subias, Pilar; Lopez-Meseguer, Manuel; Martinez-Menaca, Amaya; Perez-Olivares, Carmen et al.
DOI: 10.1016/S2213-2600(22)00290-9

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT.

PMID: 35055345
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030.
Impact factor: 4.945
Publication type: Paper in international publication
Authors: Herance, Jose Raul, Simo, Rafael, Velasquez, Mayra Alejandra, Paun, Bruno, Garcia-Leon, Daniel, Aparicio, Carolina, Mares, Roso, Simo-Servat, Olga, Castell-Conesa, Joan, Hernandez, Cristina et al.
DOI: 10.3390/jpm12010030

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT.

PMID: 35055345
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030.
Impact factor:
Publication type: Paper in international publication
Authors: Aguade-Bruix, Santiago; Aparicio, Carolina; Castell-Conesa, Joan; Garcia-Leon, Daniel; Herance, Jose Raul; Hernandez, Cristina; Mares, Roso; Paun, Bruno; Simo, Rafael; Simo-Servat, Olga et al.
DOI: 10.3390/jpm12010030

Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.

PMID: 36477027
Journal: Nature Communications
Year: 2022
Reference: Nat Commun. 2022 Dec 7;13(1):7529. doi: 10.1038/s41467-022-35065-z.
Impact factor:
Publication type: Paper in international publication
Authors: Apala, J V; Bueno, M J; Caleiras, E; Calvo, I; Cejalvo, J M; Colomer, R; Cortes, J; Fustero-Torre, C; Garcia-Saenz, J A; Gil-Gil, M et al.
DOI: 10.1038/s41467-022-35065-z

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 May 30. doi: 10.1111/liv.15327.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Martro, Elisa, Ouaarab, Hakima, Saludes, Veronica, Buti, Maria, Trevino, Begona, Roade, Luisa, Egea-Cortes, Laia, Reyes-Urena, Juliana, Not, Anna, Majo, Xavier et al.
DOI: 10.1111/liv.15327

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Aug;42(8):1751-1761. doi: 10.1111/liv.15327. Epub 2022 Jun 14.
Impact factor:
Publication type: Paper in international publication
Authors: Buti, Maria; Colom, Joan; Egea-Cortes, Laia; Gomez I Prat, Jordi; Majo, Xavier; Martro, Elisa; Not, Anna; Ouaarab, Hakima; Reyes-Urena, Juliana; Roade, Luisa et al.
DOI: 10.1111/liv.15327

Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung.

PMID: 35312541
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4.
Impact factor: 4.872
Publication type: Paper in national publication
Authors: Cruz, Maria Jesus; Millon, Laurence; Villar, Ana; Reboux, Gabriel; Morell, Ferran; Rouzet, Adeline et al.
DOI: 10.1016/j.arbres.2021.02.011

Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung.

PMID: 35312541
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4.
Impact factor:
Publication type: Paper in national publication
Authors: Cruz, Maria Jesus; Millon, Laurence; Morell, Ferran; Reboux, Gabriel; Rouzet, Adeline; Villar, Ana et al.
DOI: 10.1016/j.arbres.2021.02.011

Pineal germinoma in a young adult: A case report.

PMID: 35347869
Journal: Cancer reports (Hoboken, N.J.)
Year: 2022
Reference: Cancer Rep (Hoboken). 2022 Mar 28:e1611. doi: 10.1002/cnr2.1611.
Impact factor: 0
Publication type: Letter or abstract
Authors: Fernandez-Rodriguez, Lissett Jeanette, Maldonado-Pijoan, Xavier et al.
DOI: 10.1002/cnr2.1611

Pineal germinoma in a young adult: A case report.

PMID: 35347869
Journal: Cancer reports (Hoboken, N.J.)
Year: 2022
Reference: Cancer Rep (Hoboken). 2022 Sep;5(9):e1611. doi: 10.1002/cnr2.1611. Epub 2022 Mar 28.
Impact factor:
Publication type: Letter or abstract
Authors: Fernandez-Rodriguez, Lissett Jeanette; Maldonado-Pijoan, Xavier et al.
DOI: 10.1002/cnr2.1611

PirePred: An Accurate Online Consensus Tool to Interpret Newborn Screening Related Genetic Variants in Structural Context.

PMID: 35143952
Journal: JOURNAL OF MOLECULAR DIAGNOSTICS
Year: 2022
Reference: J Mol Diagn. 2022 Apr;24(4):406-425. doi: 10.1016/j.jmoldx.2022.01.005. Epub 2022 Feb 7.
Impact factor: 5.568
Publication type: Paper in international publication
Authors: Galano-Frutos, Juan Jose; Garcia-Cebollada, Helena; Lopez, Alfonso; Rosell, Mireia; Cruz, Xavier de la; Fernandez-Recio, Juan; Sancho, Javier et al.
DOI: 10.1016/j.jmoldx.2022.01.005